Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Tissue sulfhydryl groups

Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,824 · see citing works

GLUTATHIONE

Meister, A., & Anderson, M. E. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003431 · Cited by 5,694 · see citing works

Glutamate uptake

Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,068 · see citing works

[59] Glutathione reductase

Carlberg, I., & Mannervik, B. (1985) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(85)13062-4 · Cited by 3,009 · see citing works

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works

A simple method for determination of serum catalase activity and revision of reference range

Góth, L. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90067-m · Cited by 2,391 · see citing works

Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis

Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,110 · see citing works

Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain

Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055 · see citing works

Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis

Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796 · see citing works

Untitled work

(1995) · PubMed · Cited by 1,320 · see citing works

Radical-free biology of oxidative stress

Jones, D. P. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00283.2008 · Cited by 1,213 · see citing works

An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation

Sun, M., & Zigman, S. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90010-6 · Cited by 782 · see citing works

Amphetamine Psychosis: A "Model" Schizophrenia Mediated by Catecholamines

Snyder, S. H. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.61 · Cited by 590 · see citing works

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works

Glutamatergic mechanisms in schizophrenia

Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · see citing works

Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 543 · see citing works

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo

Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works

Structural Dimorphism in the Mitochondrial Targeting Sequence in the Human Manganese Superoxide Dismutase Gene

Shimoda‐Matsubayashi, S., Matsumine, H., Kobayashi, T., Nakagawa-Hattori, Y., Shimizu, Y., & Mizuno, Y. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1394 · Cited by 498 · see citing works

Redox dysregulation, neurodevelopment, and schizophrenia

Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works

Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation

Lipton, S. A., Choi, Y.-B., Takahashi, H., Zhang, D., Li, W., Godzik, A., & Bankston, L. A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02245-2 · Cited by 375 · see citing works

An Improved Coupled Test Procedure for Glutathione Peroxidase (EC 1.11.1.9.) in Blood

Günzler, W. A., Kremers, H., & Flohé, L. (1974) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1974.12.10.444 · Cited by 369 · see citing works

Altered glutathione redox state in schizophrenia.

Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works

Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence

Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works

Physiological Antagonism between 5-Hydroxytryptamine2A and Group II Metabotropic Glutamate Receptors in Prefrontal Cortex

Marek, G. J., Wright, R. A., Schoepp, D. D., Monn, J. A., & Aghajanian, G. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35262-0 · Cited by 280 · see citing works

Oxidative Damage and Schizophrenia

Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00004 · Cited by 280 · see citing works

Peroxidative Changes in Brain Cortical Fatty Acids and Phospholipids, as Characterized During Fe 2+ ‐ and Ascorbic Acid‐Stimulated Lipid Peroxidation In Vitro

Rehncrona, S., Smith, D. S., Åkesson, B., Westerberg, E., & Siesjö, B. K. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb11254.x · Cited by 271 · see citing works

[47] Glutathione biosynthesis; γ-glutamylcysteine synthetase from rat kidney

Seelig, G., & Meister, A. (1985) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(85)13050-8 · Cited by 265 · see citing works

NMDA receptor channels: Subunit-specific potentiation by reducing agents

Köhr, G., Eckardt, S., Lüddens, H., Monyer, H., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90311-5 · Cited by 255 · see citing works

Markers of Glutamatergic Neurotransmission and Oxidative Stress Associated With Tardive Dyskinesia

Tsai, G. E., GOFF, D. C., Chang, R. W., Flood, J. G., Baer, L., & COYLE, J. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1207 · Cited by 243 · see citing works

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

Herken, H., Uz, E., Özyurt, H., Söğüt, S., Vırıt, O., & Akyol, Ö. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238 · see citing works

Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene

Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234 · see citing works

Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia

Wang, C., McInnis, J., Ross-Sanchez, M., Shinnick‐Gallagher, P., Wiley, J. L., & Johnson, K. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00384-0 · Cited by 234 · see citing works

Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

Mahadik, S. P., Evans, D. R., & Lal, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00181-0 · Cited by 229 · see citing works

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

Matsuzawa, D., Obata, T., Shirayama, Y., Nonaka, H., Kanazawa, Y., Yoshitome, E., Takanashi, J., Matsuda, T., Shimizu, E., Ikehira, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001944 · Cited by 201 · see citing works

Free radical pathology in schizophrenia: a review

Reddy, R. D., & YAO, J. K. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90143-x · Cited by 201 · see citing works

Reduced plasma antioxidants in first-episode patients with schizophrenia

Reddy, R. D. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00407-3 · Cited by 194 · see citing works

Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference‐edited spectra

Terpstra, M., Henry, P., & Rolf Gruetter, A. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10499 · Cited by 175 · see citing works

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients

Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173 · see citing works

Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients.

Abdalla, D. S. P., Monteiro, H., Oliveira, J., & Bechara, E. J. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.5.805 · Cited by 168 · see citing works

Redox modulation of the NMDA receptor

Choi, Y., & Lipton, S. A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000638 · Cited by 165 · see citing works

Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis

Mahadik, S. P., Mukherjee, S., Scheffer, R. E., Correnti, E. E., & Mahadik, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00282-5 · Cited by 163 · see citing works

Enzymes of the antioxidant defense system in chronic schizophrenic patients

Reddy, R. D., Mahadik, S. P., Mukherjee, S., & Murthy, J. N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90298-z · Cited by 156 · see citing works

Recovery of neuropsychological functions during reduction in use of phencyclidine

Cosgrove, J., & Newell, T. G. (1991) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199101)47:1 · Cited by 138 · see citing works

Manganese Superoxide Dismutase Gene Polymorphism and Schizophrenia Relation to Tardive Dyskinesia

Hori, H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00156-6 · Cited by 130 · see citing works

Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine

Baker, D. L., Madayag, A., Kristiansen, L. V., Meador‐Woodruff, J. H., Haroutunian, V. H., & Raju, I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301532 · Cited by 112 · see citing works

Blockade of Phencyclidine-Induced Cortical Apoptosis and Deficits in Prepulse Inhibition by M40403, a Superoxide Dismutase Mimetic

Wang, C., McInnis, J., West, J. B., Bao, J., Anastasio, N. C., Guidry, J. A., Ye, Y., Salvemini, D., & Johnson, K. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041798 · Cited by 98 · see citing works

Pronounced Cell Death in the Absence of NMDA Receptors in the Developing Somatosensory Thalamus

Adams, S. M., Vaccari, J. C. D. R., & Corriveau, R. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3290-04.2004 · Cited by 80 · see citing works

The mediodorsal thalamic nucleus and schizophrenia

Alelú‐Paz, R., & Giménez‐Amaya, J. M. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0846 · Cited by 75 · see citing works

Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis

Zuo, D., Wu, Y., Yao, W.-X., Cao, Y., Wu, C., & Tanaka, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.010 · Cited by 61 · see citing works

Oxidative stress in prefrontal cortex of rat exposed to MK-801 and protective effects of CAPE

Özyurt, B., Özyurt, H., Akpolat, N., Erdoğan, H., & Sarsılmaz, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.01.029 · Cited by 46 · see citing works

Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine

Chipana, C., Garcia‐Ratés, S., Camarasa, J., Pubill, D., & Escubedo, E. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.07.016 · Cited by 36 · see citing works

BRIEF COMMUNICATION Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia

Yamada, K., Kanba, S., Anamizu, S., OHNISHI, K., Ashikari, I., Yagi, G., & Asai, M. (1997) · Psychological Medicine · doi:10.1017/s0033291797005114 · Cited by 35 · see citing works

Antioxidants attenuate MK-801-induced cortical neurotoxicity in the rat

Willis, C. L., & Ray, D. E. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.10.007 · Cited by 26 · see citing works

Substrate kinetics of erythrocyte membrane Na,K-ATPase and lipid peroxides in schizophrenia

Petronijević, N., Mićić, D. V., Duricić, B., Marinković, D., & Paunović, V. R. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00030-7 · Cited by 23 · see citing works

Baseline temperature in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration

Radonjić, N. V., Petronijević, N., Vuckovic, S. M., Prostran, M. S., Nešić, Z., Todorović, V., & Paunović, V. R. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.003 · Cited by 20 · see citing works

Redox Sensitivity of NMDA Receptors

Lipton, S. A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-683-5:121 · Cited by 17 · see citing works

Superoxide dismutase activity in the mongolian gerbil brain after acute poisoning with aluminum

Mićić, D. V., Petronijević, N., & Vučetić, S. S. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5107 · Cited by 13 · see citing works

Periadolescent nicotine exposure produces sensitization to reinforcement by diazepam in the rat

James-Walke, N. L., Williams, H. L., Taylor, D. A., & McMillen, B. A. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.09.022 · Cited by 12 · see citing works

Acetylcholinesterase Activity in the Mongolian Gerbil Brain after Acute Poisoning with Aluminum

Micic, D. V., & Petronijević, N. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-2101 · Cited by 11 · see citing works

[Analysis of platelet superoxide dismutase 1 in the development of childhood psychoses].

Golse, B., Debray-Ritzen, P., Puget, K., & Michelson, A. M. (1977) · PubMed · Cited by 11 · see citing works

Serotonergic/glutamatergic interactions: Potentiation of phencyclidine-induced stimulus control by citalopram

Winter, J. C., Eckler, J. R., Rice, K. C., & Rabin, R. A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.03.022 · Cited by 7 · see citing works

Mitogenic response to bFGF and cerebral volume in psychotic patients

Mukherjee, S., Crapanzano, K. A., Casanova, M. F., Scheffer, R. E., Correnti, E. E., Bates, P. R., Mahadik, S. P., & Mahadik, J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)94726-d · Cited by 6 · see citing works

Plasma lipid peroxidation and HVA in first episode psychosis

Scheffer, R. E., Diamond, B. I., Correnti, E. E., Borison, R. L., Mahadik, S. P., & Mukherjee, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)94727-e · Cited by 4 · see citing works

Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs

WINTER, J. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.07.007 · Cited by 3 · see citing works

Oxidative stress in schizophrenia: An integrated approach

Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 474 · see citing works

Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis

Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works

Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism

Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252 · see citing works

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

Singh, S. P., & Singh, V. (2011) · CNS Drugs · doi:10.2165/11586650-000000000-00000 · Cited by 194 · see citing works

Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia

Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.049 · Cited by 164 · see citing works

Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system

Baxter, P. S., Bell, K. F. S., Hasel, P., Kaindl, A. M., Fricker, M., Thomson, D., Cregan, S. P., Gillingwater, T. H., & Hardingham, G. E. (2015) · Nature Communications · doi:10.1038/ncomms7761 · Cited by 139 · see citing works

The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3459 · Cited by 134 · see citing works

Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons

Jiang, Z., Rompala, G. R., Zhang, S., Cowell, R. M., & Nakazawa, K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.004 · Cited by 128 · see citing works

Oxidative stress in schizophrenia - focusing on the main markers.

Ciobica, A. S., Pădurariu, M., Dobrin, I., Ștefănescu, C., & Dobrin, R. (2011) · PubMed · Cited by 126 · see citing works

Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration

Möller, M., du Preez, J. L., Emsley, R. A., & Harvey, B. H. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.09.006 · Cited by 103 · see citing works

Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia

Jiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 89 · see citing works

Cocaine-Induced Adaptations in Cellular Redox Balance Contributes to Enduring Behavioral Plasticity

Uys, J. D. K., Knackstedt, L. A., Hurt, P., Tew, K. D., Manevich, Y., Hutchens, S., Townsend, D. M., & Kalivas, P. W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.143 · Cited by 60 · see citing works

Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study

Fraguas, D., González-Pinto, A. M., Micó, J. A., Reig, S., Parellada, M., Martínez‐Cengotitabengoa, M., Castro‐Fornieles, J., Rapado‐Castro, M., Baeza, I., Janssen, J., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.040 · Cited by 57 · see citing works

Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice

Hou, Y., Zhang, H., Xie, G., Cao, X., Zhao, Y., Liu, Y., Mao, Z., Yang, J., & Wu, C. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.006 · Cited by 55 · see citing works

Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain

Stojković, T., Radonjić, N. V., Velimirović, M., Jevtić, G., POPOVIC, V. M., Doknić, M., & Petronijević, N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.013 · Cited by 53 · see citing works

Glutathione peroxidase-1 and neuromodulation: Novel potentials of an old enzyme

Sharma, G., Shin, E., Sharma, N., Nah, S.-Y., Nhu, H., Nguyen, B. T., Jeong, J. H., Lei, X. G., & Kim, H. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111945 · Cited by 53 · see citing works

N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats

Möller, M., du Preez, J. L., Viljoen, F. P., Berk, M., & Harvey, B. H. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9433-z · Cited by 48 · see citing works

The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases

Danta, C. C., & Piplani, P. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.942218 · Cited by 48 · see citing works

A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector

Davis, R. M., Sowers, A. L., DeGraff, W., Bernardo, M., Thetford, A., Krishna, M. C., & Mitchell, J. B. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.019 · Cited by 47 · see citing works

Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice

Tran, T.-V., Shin, E., Jeong, J. H., Lee, J., Lee, Y., Jang, C., Nah, S.-Y., Lei, X. G., Toriumi, K., Yamada, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0239-y · Cited by 42 · see citing works

Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia

Phensy, A. J., Driskill, C. M., Lindquist, K. A., Guo, L., Jeevakumar, V., Fowler, B., Du, H., & Kroener, S. (2017) · eNeuro · doi:10.1523/eneuro.0081-17.2017 · Cited by 40 · see citing works

Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: A 12-months follow-up study

Ruiz‐Litago, F., Seco‐Calvo, J., Echevarrı́a, E., Martínez‐Cengotitabengoa, M., Gil, J., Irazusta, J., & González-Pinto, A. M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.024 · Cited by 41 · see citing works

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice

Spencer, J. R., Darbyshire, K. M. E., Boucher, A. A., Kashem, M. A., Long, L. E., McGregor, I. S., Karl, T., & Arnold, J. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00015 · Cited by 35 · see citing works

Role of the NRG1/ErbB4 and PI3K/AKT/mTOR Signaling Pathways in the Antipsychotic Effects of Aripiprazole and Sertindole in Ketamine-Induced Schizophrenia-Like Behaviors in Rats

Nawwar, D. A., Zaki, H. F., & Sayed, R. H. (2021) · Inflammopharmacology · doi:10.1007/s10787-022-01031-w · Cited by 36 · see citing works

Mitochondrial impairment, apoptosis and autophagy in a rat brain as immediate and long-term effects of perinatal phencyclidine treatment — influence of restraint stress

Jevtić, G., Nikolić, T., Mirčić, A., Stojković, T., Velimirović, M., Trajković, V., Marković, I., Trbovich, A. M., Radonjić, N. V., & Petronijević, N. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.014 · Cited by 34 · see citing works

Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene

Tran, T.-V., Shin, E., Nguyen, L. T. T., Lee, Y., Kim, D.-J., Jeong, J. H., Jang, C., Nah, S.-Y., Toriumi, K., Nabeshima, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0638-8 · Cited by 34 · see citing works

Aberrant regulation of alternative pre-mRNA splicing in schizophrenia

Morikawa, T., & Manabe, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.08.012 · Cited by 34 · see citing works

Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study

Lu, Z., Wen, T., Wang, Y., Kan, W., & Xun, G. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02635-8 · Cited by 32 · see citing works

Glutamatergic Neuroplasticity in Cocaine Addiction

Uys, J. D. K., & Reissner, K. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00009-0 · Cited by 30 · see citing works

Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia

Samuelsson, M., Skogh, E., Lundberg, K., Vrethem, M., & Öllinger, K. M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.014 · Cited by 27 · see citing works

Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia

Zhang, Y., Catts, V. S., & Weickert, C. S. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417728805 · Cited by 26 · see citing works

Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis

Goh, X. X., Tang, P. Y., & Tee, S. F. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114429 · Cited by 25 · see citing works

Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress

Chiang, T.-I., Yu, Y., Lin, C., & Lane, H. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.3.423 · Cited by 26 · see citing works

Blood-Based Oxidation Markers in Medicated and Unmedicated Schizophrenia Patients: A Meta-Analysis

Goh, X. X., Tang, P. Y., & Tee, S. F. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102932 · Cited by 24 · see citing works

Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB.

Tran, T.-V., Park, S. J., Shin, E., Tran, H.-Q., Jeong, J., Jang, C., Lee, Y.-J., Nah, S., Nabeshima, T., & Kim, H.-C. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.11.004 · Cited by 21 · see citing works

Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia

Zugno, A. I., Pacheco, F. D., Budni, J., de Oliveira, M. B., Canever, L., Heylmann, A. S., Wessler, P. G., Silveira, F. D. R., Mastella, G. A., Gonçalves, C. L., et al. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9671-3 · Cited by 23 · see citing works

Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

Kuo, C.-Y., Lin, C., & Lane, H. (2022) · CNS Drugs · doi:10.1007/s40263-022-00959-5 · Cited by 22 · see citing works

Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1

Radonjić, N. V., Jakovčevski, I., Bumbasirevic, V. Z., & Petronijević, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2999-7 · Cited by 22 · see citing works

Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences

Sampaio, L. R. L., Filho, F. M. S. C., de Almeida, J. C., Diniz, D. D. S., Patrocínio, C. F. V., de Sousa, C. N. S., Patrocínio, M. C. A., Macêdo, D. S., & Vasconcelos, S. M. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.008 · Cited by 21 · see citing works

Prostaglandins, pain, and inflammation.

Ferreira, S. H. (1986) · PubMed · Cited by 21 · see citing works

Adolescent GBR12909 exposure induces oxidative stress, disrupts parvalbumin-positive interneurons, and leads to hyperactivity and impulsivity in adult mice

Khan, A., de Jong, L. A. W., Kamenski, M. E., Higa, K. K., Lucero, J. D., Young, J. W., Behrens, M. M., & Powell, S. B. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.022 · Cited by 18 · see citing works

Long‐Term Effects of Maternal Deprivation on Redox Regulation in Rat Brain: Involvement of NADPH Oxidase

Marković, B., Radonjić, N. V., Jevtić, G., Stojković, T., Velimirović, M., Aksić, M., Poleksić, J., Nikolić, T., Aleksić, D., Radonjić, V., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7390516 · Cited by 19 · see citing works

Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia

Beeraka, N. M., Ávila-Rodriguez, M., & Aliev, G. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02703-4 · Cited by 18 · see citing works

Schizophrenia and Glutathione: A Challenging Story

Carletti, B., Banaj, N., Piras, F., & Bossù, P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111526 · Cited by 17 · see citing works

Oxidative Stress and Schizophrenia

Huang, D., & Liu, S. (2017) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20170006 · Cited by 16 · see citing works

Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro

Barzilay, R., Ganz, J., Sadan, O., Ben‐Zur, T., Bren, Z., Hinden, N., Taler, M., Lev, N., Gil‐Ad, I., Weizman, A., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.002 · Cited by 15 · see citing works

Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction

Phensy, A. J., Lindquist, K. L., Lindquist, K. A., Bairuty, D., Gauba, E., Guo, L., Tian, J., Du, H., & Kroener, S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0880-20.2020 · Cited by 13 · see citing works

Glutathione S-transferase alpha 1 risk polymorphism and increased bilateral thalamus mean diffusivity in schizophrenia

Spalletta, G., Piras, F., Gravina, P., Bello, M. L., Bernardini, S., & Caltagirone, C. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.12.016 · Cited by 13 · see citing works

Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction

Kosten, L., Verhaeghe, J. A. J., Verkerk, R. M., Thomae, D., Picker, L. D., Wyffels, L., Eetveldt, A. V., Dedeurwaerdere, S., Stroobants, S. G., & Staelens, S. G. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.01.013 · Cited by 13 · see citing works

Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine

Nikolić, T., Petronijević, M., Sopta, J. P., Velimirović, M., Stojković, T., Dožudić, G. J., Aksić, M., Radonjić, N. V., & Petronijević, N. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0171-4 · Cited by 13 · see citing works

A fish perspective on SARS-CoV-2: Toxicity of benzalkonium chloride on Danio rerio

Sousa, B., Domingues, I., & Nunes, B. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104200 · Cited by 12 · see citing works

Ontogenetic influence on rat susceptibility to lindane seizure after pretreatment with phencyclidine

Stanojlović, O. P., Nikolić, T., Hrnčić, D., Radonjić, N. V., Rašić-Marković, A., Mladenović, D. R., & Petronijević, N. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.12.006 · Cited by 12 · see citing works

Neuroteratology and Animal Modeling of Brain Disorders

Archer, T., & Kostrzewa, R. M. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_434 · Cited by 13 · see citing works

The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies

Schiavone, S., & Trabace, L. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12847 · Cited by 10 · see citing works

Clozapine attenuates mitochondrial burdens and abnormal behaviors elicited by phencyclidine in mice via inhibition of p47 phox ; Possible involvements of phosphoinositide 3-kinase/Akt signaling

Tran, H., Park, S. J., Shin, E., Tran, T.-V., Sharma, N., Lee, Y. J., Jeong, J. H., Jang, C., Kim, D.-J., Nabeshima, T., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118795244 · Cited by 10 · see citing works

Region-specific reduction of parvalbumin neurons and behavioral changes in adult mice following single exposure to cranial irradiation

Ueno, H., Suemitsu, S., Murakami, S., Kitamura, N., Wani, K., Matsumoto, Y., Okamoto, M., & Ishihara, T. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1564081 · Cited by 9 · see citing works

Effects of Antipsychotics on the Hypothalamus–Pituitary–Adrenal Axis in a Phencyclidine Animal Model of Schizophrenia

Nikolić, T., Velimirović, M., Stojković, T., Kanazir, S., Lončarević‐Vasiljković, N., Radonjić, N. V., Popić, J., & Petronijević, N. (2024) · Cells · doi:10.3390/cells13171425 · Cited by 8 · see citing works

Neural changes induced by antipsychotic administration in adolescence: A review of studies in laboratory rodents

Moe, A. A. K., Scott, J. G., Burne, T. H. J., & Eyles, D. W. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116654776 · Cited by 8 · see citing works

Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia

Petronijević, N., Sopta, J. P., Doknić, M., Radonjić, N. V., Petronijević, M., Pekić, S., Marić, N. P., Jašović‐Gašić, M., & POPOVIC, V. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.013 · Cited by 8 · see citing works

Effects of isolation rearing and early antipsychotic intervention on oxidative stress-induced apoptosis and brain-derived neurotrophic factor in hippocampus in a rat model of schizophrenia

Liu, Y.-P., Yang, S., Yang, Y.-Y., Wan, F.-J., & Huang, C. (2017) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_113_16 · Cited by 7 · see citing works

Esquizofrenia: uma doença inflamatória?

Aguiar, C. C. T., Alves, C. D., Rodrigues, F. A. R., Barros, F. W. A., de Sousa, F. C. F., Vasconcelos, S. M. M., & Macêdo, D. S. (2010) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852010000100008 · Cited by 6 · see citing works

Association between redox dysregulation and vulnerability to cognitive deficits induced by maternal immune activation

McEwan, F., Kambara, C., Lorusso, J. M., Harte, M., Glazier, J. D., & Hager, R. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03398-0 · Cited by 3 · see citing works

The role of saffron and its main components on oxidative stress in neurological diseases: A review

Nassiri‐Asl, M., & Hosseinzadeh, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817780-8.00023-2 · Cited by 3 · see citing works

Neuroprotective Effect of Quercetin in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Model of Parkinson’s Disease

Nazif, N. N., Khosravi, M., Ahmadi, R., Bananej, M., & Majd, A. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.8.1.1 · Cited by 3 · see citing works

Apocynin-tandospirone derivatives demonstrate antioxidant properties in the animal model of schizophrenia

Uehara, T., Kurachi, M., Kondo, T., Abe, H., Zhao, Q., Itoh, H., Sumiyoshi, T., & Suzuki, M. (2021) · Advances in Redox Research · doi:10.1016/j.arres.2021.100013 · Cited by 2 · see citing works

Embryonic Deletion of TXNIP in GABAergic Neurons Enhanced Oxidative Stress in PV+ Interneurons in Primary Somatosensory Cortex of Aging Mice: Relevance to Schizophrenia

Xue, T., Wang, X., Hu, Y. C., Cheng, Y., Li, H., Shi, Y., Wang, L., Yin, D., & Cui, D. (2022) · Brain Sciences · doi:10.3390/brainsci12101395 · Cited by 2 · see citing works

The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood

Lorenc‐Koci, E., Górny, M., Chwatko, G., Kamińska, K., Iciek, M., & Rogóż, Z. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00607-3 · Cited by 1 · see citing works

What Does Proteomics Tell Us About Schizophrenia

Martins-de-Souza, D., Gattaz, W., Schmitt, A., Maccarrone, G., Falkai, P., Bahn, S., Dias-Neto, E., & Turck, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_16 · Cited by 1 · see citing works

Papel do estresse oxidativo na etiologia da esquizofrenia: revisão sistemática / Role of oxidative stress in the etiology of schizophrenia: systematic review

Neto, J. M. F. A., & Nalesso, A. M. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n5-059 · Cited by 1 · see citing works

Schizophrenie und oxidativer Stress: Veränderungen des antioxidativen Schutzsystems (AODS) bei erst- und wiedererkrankten unbehandelten Patienten

Neuhaus, D. (2015) · Common Library Network (Der Gemeinsame Bibliotheksverbund)

Effect of Phencyclidine on Neuregulin Expression, Cortical Interneurons, and Redox Dysregulation

Petronijević, N., & Radonjić, N. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00057-1

Schizophrenia and osteoporosis

Nikolić, T., & Petronijević, N. (2018) · Medicinski podmladak · doi:10.5937/mp69-17304

Parvalbumin Interneuron Damage Plays a Central Role in the Pathogenesis of Schizophrenia

陈, 默. (2019) · International Journal of Psychiatry and Neurology · doi:10.12677/ijpn.2020.91001

The predictive potential and relationship of peripheral non-enzymatic antioxidants with clinical symptoms in first-episode male adolescent-onset schizophrenia patients

Du, B., Ma, J., Chen, H., Zhang, K., Wang, Z., Zhao, Z., Li, H., Meng, X., & Liu, Z. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00628-7

Mécanismes dopaminergiques des symptômes schizophréniques et nouvelles perspectives de modulation thérapeutique

Rolland, B. (2012) · doi:10.70675/a84a5cf1z0edaz4b70z8aabz8e681b5e2700

Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain

Stojković, T., Radonjić, N. V., Velimirović, M., Jevtić, G., POPOVIC, V. M., Doknić, M., & Petronijević, N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.013 · Cited by 53 · see citing works

The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood

Lorenc‐Koci, E., Górny, M., Chwatko, G., Kamińska, K., Iciek, M., & Rogóż, Z. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00607-3 · Cited by 1 · see citing works

PM377. Role of glutathione peroxidase-1 gene in the phencyclidine-induced schizophrenia-like psychosis in mice

Tran, T.-V., Dang, D., Tran, H., Shin, E., Jang, C., Yamada, K., Nabeshima, T., & Kim, H. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw041.377 · Cited by 2 · see citing works

Association between three genetic polymorphisms of glutathione S-transferase Z1 (GSTZ1) and susceptibility to schizophrenia

Nafissi, S., Saadat, I., Farrashbandi, H., & Saadat, M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.11.024 · Cited by 14 · see citing works

Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice

Tran, T.-V., Shin, E., Jeong, J. H., Lee, J., Lee, Y., Jang, C., Nah, S.-Y., Lei, X. G., Toriumi, K., Yamada, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0239-y · Cited by 42 · see citing works